Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-25 @ 3:04 PM
NCT ID:
NCT00498368
Group ID:
EG000
Title:
Rituximab Plus ACE/ARB
Description:
Intravenous Rituximab therapy, ACE/ARB combination therapy, and Omega-3 Fatty Acid Fish Oil Supplement
Intravenous Rituximab: Rituximab Therapy \[27 Patients\]
* Rituximab 1 gm IV on Treatment Day 1
* Rituximab 1 gm IV on Treatment Day 15
* Rituximab 1 gm IV on Treatment Day 168
* Rituximab 1 gm IV on Treatment Day 182
* An angiotensin converting enzyme (ACE) inhibitors and /or angiotensin II receptor blockers (ARBs) will be used to achieve a B/P goal of \<130/80 millimeters of mercury
Omega-3 Fatty Acid Fish Oil Supplement: Omega-3 Fatty Acid Fish Oil Supplement 3.6 gm eicosapentaenoic acid (EPA)/day
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
17
Other Number Affected:
0
Other Number At Risk:
17
Study:
NCT00498368
Results Section:
NCT00498368
Adverse Events Module:
NCT00498368